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Summary 
Ly-49 is a recently identified cell surface molecule expressed on a subpopulation of natural killer 
(NK) ceils  and certain  T  lymphomas.  It has  been suggested,  based on gene transfection  and 
antibody blocking studies,  that Ly-49 is a negative regulator of NK lytic activity, possibly through 
an interaction  with  target  cell class  I molecules.  However, it has  not been demonstrated  that 
class I molecules indeed serve as ligands for Ly-49. We have found that T lymphomas expressing 
Ly-49 bind isolated class  I major histocompatibility complex (MHC) molecules but not class 
II molecules immobilized on plastic. Adhesion to class I molecules was not found with T lymphomas 
lacking Ly-49 expression.  The Ly-49 expressing EL4 lymphoma bound D a, D k,  and K b, but 
not K d, K k,  or D b, thus demonstrating  a restricted pattern  of class I adhesion.  The observed 
cell adhesion was class I density dependent, and binding to D a and D k was extensively inhibited 
by the A1 monoclonal  antibody directed against  Ly-49. These results provide direct evidence 
for Ly-49 serving as a receptor for a subset of class  I MHC molecules. 
L 
-49 is a disulfide-linked cell surface homodimer that con- 
sists of two 44-kD subunits and is normally expressed 
on a subpopulation of NK cells in certain strains of mice (1, 
2). The orientation of Ly-49 in the plasma membrane (COOH 
terminus to the cell exterior) is that of a typical type II mem- 
brane protein, and the extracellular domain demonstrates ho- 
mology to  the C-type lectins  (1,  2).  Ly-49 is the product 
of a gene belonging to a newly identified gene family that 
maps to a region on mouse chromosome 6 termed the "NK 
gene complex" (2). Products from other members of this gene 
family are also expressed on NK cells and,  although  struc- 
turally related, demonstrate considerable heterogeneity in pri- 
mary sequence (3). A human multigene family has also been 
identified which shows homology to genes of the mouse NK 
gene complex (4). 
Expression of certain class I MHC molecules on target cells 
can often, but not always, inhibit NK lysis (5). A dass I MHC 
protective effect has been given strong support from studies 
showing that transfection  of certain class I molecules can confer 
resistance to otherwise NK-susceptible targets (6, 7). Recently, 
it has been demonstrated that antibodies to Ly-49 significantly 
reduce protection from IL-2-activated NK lysis conferred by 
expression of transfected class I genes in normally NK-suscep- 
tible targets (7). These results suggested that Ly-49 may be 
a receptor for class I molecules and that, perhaps upon en- 
gagement, Ly-49 transmits a signal that negatively regulates 
NK lytic activity. 
In addition to NK cells,  Ly-49 is expressed on certain T 
lymphoma cell lines (1). Interactions of Ly-49-expressing T 
lymphomas with isolated MHC molecules were examined 
and evidence is provided to indicate that certain class I MHC 
products  are indeed ligands  for Ly-49. 
Materials  and Methods 
Cell Lines.  The  T  cell lymphomas  EL4,  EL4.IL-2 subline, 
YAC-1, and TIMI.4 were obtained from American Type Culture 
Collection  (Rockville, MD). The EL4.IL2 subline, unlike EL4, 
secretes IL-2 upon appropriate stimulation  (8). All T lymphomas 
assayed for adhesion to MHC molecules, including those mentioned 
above and RDM-4, an AKR lymphoma,  were grown in DMEM 
(GIBCO BRL, Burlington,  ON, Canada) supplemented with 2% 
heat-inactivated FCS (HI-FCS) (Hyclone Laboratories, Logan, UT), 
5% heat-inactivated defined calf serum (HI-DCS) (Hyclone Labora- 
tories), 20 mM Hepes, 2 mM t-glutamine, and 100 #g/ml penicillin- 
streptomycin. The A20 B cell lymphoma was kindly provided by 
Dr.  A. O'Rourke (Scripps Clinic, La JoUa, CA) and was grown 
in DMEM supplemented with 5% HI-DCS, 20 mM Hepes and 
2 mM r-glutamine. 
Class I and 11Protein  Purification  and Immobilization.  Class  I MHC 
proteins were isolated from RDM-4 (H-2 k) and EL4 (H-2  b) grown 
as ascites in syngeneic AKR (H-2 k) and C57BL/6 (H-2  b) mice and 
from A20 (H-2  d) cells grown in vitro.  The H-2K  ~, D k, K  b, and 
D b proteins were purified by mAb-affmity chromatography as pre- 
viously described (9). The H-2D  a and K a molecules were purified 
from A20 cells by mAb-affinity chromatography  methods previ- 
ously described (9), with the following modification: H-2D  a and 
K d were obtained by sequential passage of A20 cell lysates over a 
34-5-8S (D~-specific)  column and an M1/42 (pan-H-2) column for 
K a, rather than differential elution from a single M1/42 column. 
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MK-D6 and 14-4-4S columns as previously described (10). Purified  EL4 
MHC proteins were quantitated by bicinchoninic acid (BCA) pro- 
tein determination (Pierce, Rockford, IL) and ELISA (9). Purity 
of the isolated MHC preparations was verified by SDS-PAGE and  EL4.1L2 
Coomassie brilliant  blue or silver staining. 
Purified  MHC proteins were immobilized in microtiter wells 
(Falcon Microtest III; Becton Dickinson,  Oxnard, CA) for cell adhe- 
sion assays as previously described  (9).  Briefly, MHC proteins  in  YAC-1 
detergent were diluted in Dulbecco's PBS (D-PBS) and incubated 
in plastic microtiter wells for 1.5 h at room temperature. Unbound 
protein was removed by washing and remaining sites on the plastic 
blocked with a 2% FCS/D-PBS solution. A 1% solution of BSA  RDM-4 
(Fraction V; Sigma Chemical Co., St. Louis, MO) was used to bind 
control wells which were then blocked with 2%  FCS/D-PBS. 
Antibodies and Hybridoma Supernatants.  mAbs used  in  these  TIMI.4 
studies include A1, anti-Ly-49 (11); 53-6.72, anti-CD8 (12); GK1.5, 
anti-CD4, (13); H57-597, anti-TCR t8 chain (14); F23.1, anti-TCR 
V~8 (15), 34-5-8S,  anti-D a crick2 domain epitope (16); 34-2-12S, 
anti-D d c~3 domain  epitope  (16) and  15-5-5S, anti-D k (17) that 
were in the form of hybridoma supernatants or reconstituted am- 
monium sulfate precipitates from supernatants of hybridomas grown 
in Protein Free Hybridoma Medium-II (GIBCO BRL). 
Assay of Cell Adhesion.  The method used to determine cell adhe- 
sion in microtiter wells bearing MHC proteins has been described 
in detail (18). Briefly, cells were labeled by incubation for I h with 
100/zCi Na51CrO4, washed,  resuspended  in DMEM containing 
2%  FCS,  and added  to wells  at  10  s cells/well  in 0.1  ml.  Plates 
were centrifuged for 1 min at 400 rpm and incubated for 1 h or 
the indicated  time at 37~  in a CO2 incubator.  In experiments 
using mAbs directed against EL4 cell surface molecules, the purified 
antibodies  or hybridoma supernatants were added  to the cells in 
suspension  20 min before addition of the cells to the wells. In ex- 
periments employing mAbs directed against the plate-bound class 
I, hybridoma supernatants were incubated in wells bearing class 
I for 20 min before addition of EL4 cells. At the end of the cell 
incubation on MHC-coated plates,  an aliquot of supernatant was 
harvested from all wells to determine spontaneous release, then un-  100 
bound cells were removed,  the well bottoms cut off, and radioac- 
tivity determined.  Cell binding was calculated as percent cells bound 
=  100  x  (cpm bound/total cpm -  spontaneous cpm). Measure- 
ments were done in triplicate  for each condition and error bars in 
the figures  show standard deviation. 
Results 
T Lymphomas Expressing Ly-49 Bind Isolated Class I Mole- 
cules.  We reasoned that ifLy-49 is a receptor for class I MHC 
molecules then T lymphomas that express Ly-49 might bind 
class I molecules. This was tested with three T  lymphomas 
known to express Ly-49, EL4, EL-4.IL-2, and  TIMI.4 (1) 
and two T  lymphomas that  do not  express  this  molecule, 
YAC-1 and RDM-4 (data not shown). Radiolabeled cell adhe- 
sion  was  observed  to  H-2D  a but  not  IE  d or  BSA coated 
wells by Ly-49-expressing cells, particularly EL4 and TIMI.4, 
whereas the Ly-49 negative cells did not bind any of the im- 
mobilized proteins to significant levels (Fig. 1). A significantly 
lower percentage of EL4.IL2 cells bound D d in the adhesion 
assay than did EL4 (Fig. 1). We have determined that EL4.IL-2 
expresses a substantially lower level of Ly-49 than EL4 using 
a FACScan  |  instrument  (Becton Dickinson &  Co., Moun- 
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Figure  1.  Ly-49-expressing  T lymphomas bind immobilized D d. Im- 
munoaffinity-purified H-2D d or IE  d in detergent were diluted separately 
in D-PBS and immobilized at 0.07/zg/well  in plastic microtiter wells as 
described in Materials and Methods. BSA (0.1 #g/well) was immobilized 
in control wells. The indicated T lymphoma cell lines were labeled for 
1 h with Na251CrO4 and 105 cells were incubated in each well for 1 h 
at 37~  Unbound cells were removed and cell binding was quantitated 
for individual plate wells by "y-counting as described in Materials and 
Methods. Spontaneous release for all cell lines was <5%. Results are rep- 
resented as the mean percent of input cells bound and the SD from tripli- 
cate wells. 
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Figure 2.  Specificity  and density dependence of EL4 binding to iso- 
lated class I molecules. Purified class I or II MHC molecules were im- 
mobilized at the densities indicated, as described  in Materials and Methods. 
slCr-labeled EL4 cells (10  s) were added to each well and incubated for 
1 h and cell binding was determined by y-counting. Background  binding 
of EL4 on wells bound with BSA and blocked with 2% FCS/D-PBS  was 
determined to be 4%, and this value was subtracted to give the percent 
specific cell binding shown. Spontaneous SlCr release for the EL4 cells 
was <5%. 
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tent with Ly-49 mediating the cell adhesion to isolated D a. 
Specificity and Density Dependence of EL4 Binding to Isolated 
Class I Molecules.  We next determined whether the adhe- 
sion by EL4 was specific for D a or could be extended to in- 
clude other class I molecules. We have determined previously 
that the density of all class I molecules in plate wells is directly 
proportional to the input level of class I applied to the well, 
increases in a linear fashion, and plateaus at comparable den- 
sities (9). The density of a number of class I molecules was 
varied on the plate wells within the range of class I densities 
commonly found on normal cells (19). We found that EL4 
could bind D d and K b detectably at relatively low densities 
and cell binding increased linearly with increasing densities 
of D a and K b (Fig.  2).  Substantial EL4 binding  to D k was 
also detected, but at a significantly higher density than that re- 
quired for equivalent D d or K b binding.  Significant binding 
of EL4 to K a, D b, K k, or the class II IE  a control molecule, 
however, was not observed at any density. These results sug- 
gest that the receptor(s) mediating EL4 adhesion may differ 
in its affinity for different class  I  products. 
Antibodies  to Ly-49 Block EL4 Adhesion to D d and D k Class 
I MHC Molecules.  The preceding results indicated that EL4 
cells bind certain class I molecules.  We attempted to block 
adhesion of EL4 cells with a variety of hybridoma superna- 
rants or purified antibodies specific for Ly-49, the TCK, as 
well as CD4  and CD8,  two molecules capable of binding 
MHC molecules which are not normally expressed on these 
cells.  Substantial blocking  of EL4 adhesion  to D k and D a 
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Figure 3.  Anti-Ly-49  blocks EL4 adhesion to class I MHC molecules. 
(A) Purified H-2D k was immobilized at 0.2 #g/well. After washing and 
blocking of plate wells, 10  s slCr-labeled EL4 cells were added which had 
been preincubated  with the following  hybridoma  supernatants as indicated: 
Al(anti-Ly-49), H57-597 (anti-TCR-fl  pan specific),  GK1.5, (CD4 specific), 
and 53-6.72, (CD8 specific), at a 1:8 dilution, or in medium alone (No 
Ab). The percent specific EL4 cell binding was determined after 1 h of 
incubation. (B) Purified H-2D a was immobilized at 0.048/*g/well and 
105 slCr-labeled EL4 cells were added which had been preincubated with 
25 #g/ml of purified A1, H57-597, F23.1 (anti-TCP, VflS), GKI.5, 53- 
6.72, or medium alone. Cell binding was determined after I h of incuba- 
tion. Results are shown as mean percent binding with SD from triplicate 
wells minus nonspecific  cell adhesion to BSA-coated  plates (<5%). Spon- 
taneous release for the EL4 cells in A and B was <5%. 
was observed in the presence of purified A1 (anti-Ly-49) an- 
tibody or A1 hybridoma supernatants, whereas purified an- 
tibodies  or antibody-containing  supernatants  specific for a 
conserved TCP, 3  chain determinant, CD4 or CD8, had only 
modest effects on binding (Fig. 3, A  and B). EL4 adhesion 
to isolated K b is not blockable with any of these antibodies 
including A1 (data not shown), suggesting that K b may not 
be bound by EL4 via TCP,,  CD4,  CD8,  or Ly-49. These 
results directly implicate Ly-49 as the membrane receptor medi- 
ating adhesion of EL4 to isolated D a and D k, but probably 
not  to K b. 
Antibodies Recognizing Distinct D a Epitopes Block EL4 Ad- 
hesion to Affinity-purified D a.  Two antibodies specific for D a, 
34-5-8S,  directed against  an crl/cz2 domain,  and 34-2-12S, 
an c~3 domain-specific antibody,  significantly blocked EL4 
adhesion to isolated D a,  as did anti-Ly-49 (A1), indicating 
that D O  is indeed the mAb affinity-purified molecule bound 
by Ly-49 on EL4 cells (Fig. 4).  The 34-5-8S blocked more 
completely than did 34-2-12S,  suggesting  that  the moiety 
recognized by Ly-49 may reside in the polymorphic otl/ot2 
domains  of D a.  Blocking of EL4 adhesion  to D a was  not 
observed with an antibody directed against H-2D k (Fig. 4). 
Kinetics  of EL4 Adhesion  to D d and D k Class I  Molecules. 
EL4 binding  to D d and D k class  I  molecules was followed 
over time. EL4 adhesion was found to be fairly rapid, with 
half-maximal binding achieved in 10-20 rain and maximal 
binding approached within an hour for D a and D k (Fig. 5). 
Binding  was  sustained  for at  least  4  h  at  nearly maximal 
binding levels, suggesting a very stable interaction. Maximal 
binding to D k plateaus at a lower percentage of cells bound 
than D ~  consistent with the affinity of Ly-49 for D a being 
greater than  that  for D k. 
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Figure 4.  Antibodies recognizing distinct D d epitopes block EL4 adhe- 
sion to affinity purified D a.  Purified H-2D d was immobilized at 0.1 
/zg/well. After washing and blocking with 2% FCS/D-PBS, the plate  wells 
were incubated with hybridoma supernatants specific  for D a al/a2 do- 
main (34-5-8S), D o cx3 domain (34-2-12S), or D k (15-5-5S) at a 1:3 dilu- 
tion, or with medium alone (-). 10  s 51Cr-labeled EL4 cells preincubated 
with or without purified A1 (anti-Ly-49) at 25/xg/ml were then added. 
EL4 binding was determined after 1 h of incubation. Results are shown 
as mean percent binding with SD from triplicate wells minus nonspecific 
cell adhesion to BSA-coated  plates (<5%). Spontaneous  release  for the EL4 
cells was <5%. 
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Figure 5.  Kinetics  of EL4 adhesion  to class I. Each  purified  MHC mol- 
ecule was immobilized  at a density  that gave maximal  EL4 binding, D  a 
(0.1/zg/well), D  k (0.2/zg/well) and the IE  a control (0.2 #g/well) as de- 
scribed in Materials and Methods. Labeled  EL4 cells were added simul- 
taneously  to the wells and cell binding to D  a (squares),  D k (triangles),  and 
IE  a (circles) was determined  at the indicated  times  as described  in Materials 
and Methods. Results  are shown as mean percent binding  with SD from 
triplicate  wells  minus  nonspecific  cell  adhesion  to BSA-coated  plates (<5 %). 
Spontaneous release from EL4 cells was <10% for all time points. 
Discussion 
Our results demonstrate that the Ly-49 bearing EL4 T lym- 
phomas binds isolated H-2D  a and D k molecules in a density- 
dependent manner and that the adhesion is inhibitable by 
an antibody to Ly-49. The class I binding specificity seen with 
EL4 includes that predicted for Ly-49 on NK cells in a previous 
study (7). In that report, D a and an H-2  k product were sus- 
pected of being ligands because they conferred protection from 
Ly-49 + NK cell-mediated lysis, and the protection was di- 
minished by antibodies to Ly-49 (7).  We predict from our 
results that D k is the H-2 k haplotype product recognized by 
Ly-49 and conferred the previously observed target cell resis- 
tance to Ly-49 + NK cell lysis. The direct demonstration of 
Ly-49-dependent cell adhesion to class I molecules described 
in this study defines a new type of receptor for class I mole- 
cules  encoded in the murine NK complex. 
It is well established  that expression of certain class I mol- 
ecules on target cells can confer resistance  to NK lysis (5). 
Two alternative models have been proposed to explain the 
protective effect mediated by class I molecules: (a) class I mol- 
ecules expressed on target cells bind target structure(s) essen- 
tial for NK recognition, rendering them unrecognizable to 
NK cells (20); and (b) NK cells express receptors that directly 
interact with target cell class I molecules and upon engage- 
ment deliver negative signals to the NK cell, thus preventing 
lethal hit delivery (5). The Ly-49-dependent class I binding 
observed in this study provides evidence that strongly favors 
the second model. The nature of any regulatory signals that 
may be delivered by Ly-49 engagement with class I however, 
remains to be established. 
The  NK  cell  repertoire  differs between individuals ex- 
pressing different class I MHC alleles and can be altered in 
mice by class I transgenes (21) or allogeneic  bone marrow 
chimerism (22). In the case of Ly-49, expression is found on 
a subset of C57BL/6 (H-2  b) NK cells but not on NK cells 
from D a- or H-2k-expressing  animals (22). It has been pro- 
posed that a high-affinity interaction between D a and Ly-49 
may result in a potent negative signal leading to deletion of 
Ly-49 + NK cells or reduction of Ly-49 expression (22). Our 
results would suggest that the affinity of Ly-49 for D d is in- 
deed much higher than at least three other class I molecules 
(K  s,  K k, and D b) to which EL4 binding could not be de- 
tected, and somewhat higher than a fourth (Dk), based on 
differences in class I density requirements for EL4 adhesion. 
The intermediate affinity of Ly-49 for D k is still sufficient 
to protect target cells in NK assays  in vitro and mediate nega- 
tive selection or downregulation of Ly-49 expression observed 
in vivo. 
It is possible that the reason a number of H-2b-expressing 
targets are lysed effectively by Ly-49 + NK cells is that Ly-49 
has an affinity for K b and D b products on these particular 
targets that is too low to negatively regulate NK cells. Per- 
haps the affinity of Ly-49 for K b or D b is influenced posi- 
tively or negatively by differences in the repertoire of endog- 
enous peptides displayed by K b or D b on a given target cell 
type. We found that Ly-49 + EL4 cells did not bind isolated 
D b isolated from EL4, however EL4 cells did bind isolated 
K b molecules.  Binding of EL4 to K b is not inhibited by the 
Ly-49-specific A1 antibody (data not shown), suggesting that 
another, yet to be defined receptor,  may mediate EL4 adhe- 
sion to the "self' K  b molecule. The inability of TCR-specific 
antibodies to block EL4 adhesion to K b (data not shown) 
suggests that a high affinity "anti-self' TCR, is not likely 
to be responsible  for the observed  adhesion. Because of the 
potential complication of other uncharacterized receptor(s) 
on EL4 and TIMI.4 for K b,  interaction of Ly-49 with K b 
may not be readily assessed using these T  lymphomas. 
Ly-49 and other molecules encoded within the NK com- 
plex show homology to a superfamily of type II transmem- 
brane proteins including C-type (Ca  2+  dependent), carbo- 
hydrate binding receptors (23). Although specific  carbohydrates 
are the structures recognized by bona fide C-type lectins within 
this superfamily, the structural aspects enabling certain class 
I molecules to serve as ligands for Ly-49 have not been deter- 
mined. We found here that an antibody directed against the 
NH2-terminal oll/cr2 domains of D d (34-5-8S)  was more 
effective than a membrane-proximal a3 domain (34-2-12S)- 
specific antibody at blocking EL4 adhesion, suggesting that 
some portion of the polymorphic otl/ot2 domains of D a 
may be particularly important for Ly-49 recognition. The 
adhesion assay system described in this report, using Ly-49-ex- 
pressing lymphomas and isolated class I MHC molecules, may 
provide a valuable means by which class I structural require- 
ments for Ly-49 recognition can be characterized. 
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